0001567619-19-013522.txt : 20190618 0001567619-19-013522.hdr.sgml : 20190618 20190618113052 ACCESSION NUMBER: 0001567619-19-013522 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190618 DATE AS OF CHANGE: 20190618 EFFECTIVENESS DATE: 20190618 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OncoMyx Therapeutics, Inc. CENTRAL INDEX KEY: 0001779436 IRS NUMBER: 832289356 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-342178 FILM NUMBER: 19902948 BUSINESS ADDRESS: STREET 1: 445 N 5TH ST CITY: PHOENIX STATE: AZ ZIP: 85004 BUSINESS PHONE: (858) 945-2703 MAIL ADDRESS: STREET 1: 445 N 5TH ST CITY: PHOENIX STATE: AZ ZIP: 85004 D 1 primary_doc.xml X0708 D LIVE 0001779436 OncoMyx Therapeutics, Inc. 445 N. 5th St. Phoenix AZ ARIZONA 85004 (858) 945-2703 DELAWARE None None Corporation true 2018 Steven J. Potts, Ph.D. 445 N. 5th St. Phoenix AZ ARIZONA 85004 Director Executive Officer President and Chief Executive Officer Michael G. Wood 445 N. 5th St. Phoenix AZ ARIZONA 85004 Executive Officer Chief Financial Officer, Chief Operating Officer and Secretary Kanad Das, Ph.D. 445 N. 5th St. Phoenix AZ ARIZONA 85004 Director Ting Xiao 445 N. 5th St. Phoenix AZ ARIZONA 85004 Director Jason Rushton 445 N. 5th St. Phoenix AZ ARIZONA 85004 Director Douglas Grant McFadden, Ph.D. 445 N. 5th St. Phoenix AZ ARIZONA 85004 Director Biotechnology Decline to Disclose 06b false 2019-06-04 false true false 0 25000002 8000001 17000001 false 8 0 0 0 false OncoMyx Therapeutics, Inc. /s/ Michael G. Wood Michael G. Wood CFO, COO and Secretary 2019-06-14